Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Cardiovascular safety profile of combretastatin a4 phosphate in a single-dose phase I study in patients with advanced cancerMatthew M Cooney, Tomas Radivoyevitch, Afshin Dowlati, et al.
Investigational New Drugs|September 24, 2009
A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumorsCharles J Nock, Joanna M Brell, Joseph A Bokar, et al.
Clinical Genitourinary Cancer|October 1, 2008
Phase I/II trial of 5-fluorouracil and a noncytotoxic dose level of suramin in patients with metastatic renal cell carcinomaSaby George, Robert Dreicer, Jessie J L Au, et al.
Cancer Chemotherapy and Pharmacology|November 13, 2004
A phase IB clinical and pharmacokinetic study of the angiogenesis inhibitor SU5416 and paclitaxel in recurrent or metastatic carcinoma of the head and neckMatthew M Cooney, Kou-Yi Tserng, Vinit Makar, et al.
Cancer Chemotherapy and Pharmacology|February 10, 2011
A phase I study of MN-029 (denibulin), a novel vascular-disrupting agent, in patients with advanced solid tumorsAlejandro D Ricart, Edward A Ashton, Matthew M Cooney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2009
A phase I study of sunitinib plus bevacizumab in advanced solid tumorsBrian I Rini, Jorge A Garcia, Matthew M Cooney, et al.
Thyroid : Official Journal of the American Thyroid Association|March 7, 2009
A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcomeColin J Mooney, Govardhanan Nagaiah, Pingfu Fu, et al.
The New England Journal of Medicine|August 6, 2015
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate CancerChristopher J Sweeney, Yu-Hui Chen, Michael Carducci, et al.
Cancer Chemotherapy and Pharmacology|April 17, 2008
Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabineSmitha S Krishnamurthi, Joanna M Brell, Charles L Hoppel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2018
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED TrialChristos E Kyriakopoulos, Yu-Hui Chen, Michael A Carducci, et al.
Pageof 4